These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3232275)
1. The in vitro and in vivo effects of extracorporeal shock waves on malignant cells. Randazzo RF; Chaussy CG; Fuchs GJ; Bhuta SM; Lovrekovich H; deKernion JB Urol Res; 1988; 16(6):419-26. PubMed ID: 3232275 [TBL] [Abstract][Full Text] [Related]
2. Combined shock-wave and immunogene therapy of mouse melanoma and renal carcinoma tumors. Song J; Tata D; Li L; Taylor J; Bao S; Miller DL Ultrasound Med Biol; 2002 Jul; 28(7):957-64. PubMed ID: 12208340 [TBL] [Abstract][Full Text] [Related]
3. [Anti-neoplastic activity of a human recombinant tumor necrosis factor (Hu-rec-TNF) alone or in combination with human recombinant gamma-interferon, doxorubicin or cis-platinum on a human renal cell carcinoma line]. Gohji K; Hamami G; Kamidono S Hinyokika Kiyo; 1987 Mar; 33(3):329-35. PubMed ID: 3113191 [TBL] [Abstract][Full Text] [Related]
4. Mouse-human chimeric anti-epidermal growth factor receptor antibody C225 inhibits the growth of human renal cell carcinoma xenografts in nude mice. Prewett M; Rothman M; Waksal H; Feldman M; Bander NH; Hicklin DJ Clin Cancer Res; 1998 Dec; 4(12):2957-66. PubMed ID: 9865906 [TBL] [Abstract][Full Text] [Related]
5. Enhanced sensitivity of bladder cancer cells to cisplatin mediated cytotoxicity and apoptosis in vitro and in vivo by the selective cyclooxygenase-2 inhibitor JTE-522. Mizutani Y; Nakanishi H; Li YN; Sato N; Kawauchi A; Miki T J Urol; 2004 Oct; 172(4 Pt 1):1474-9. PubMed ID: 15371874 [TBL] [Abstract][Full Text] [Related]
6. Enhancement of chemotherapeutic effects with focused shock waves: extracorporeal shock wave chemotherapy (ESWC). Kambe M; Ioritani N; Kanamaru R Hum Cell; 1997 Mar; 10(1):87-94. PubMed ID: 9234069 [TBL] [Abstract][Full Text] [Related]
7. In vitro effects of high energy shock wave alone and combined with anticancer drugs on human bladder cancer cells. Rahman M Urol Int; 1994; 53(1):12-7. PubMed ID: 7974879 [TBL] [Abstract][Full Text] [Related]
8. Antitumor effect of bcl-2 antisense phosphorothioate oligodeoxynucleotides on human renal-cell carcinoma cells in vitro and in mice. Uchida T; Gao JP; Wang C; Satoh T; Itoh I; Muramoto M; Hyodo T; Irie A; Akahoshi T; Jiang SX; Kameya T; Baba S Mol Urol; 2001; 5(2):71-8. PubMed ID: 11690551 [TBL] [Abstract][Full Text] [Related]
9. The combined effects of shock waves and cisplatin therapy on rat prostate tumors. Holmes RP; Yeaman LI; Li WJ; Hart LJ; Wallen CA; Woodruff RD; McCullough DL J Urol; 1990 Jul; 144(1):159-63. PubMed ID: 2359170 [TBL] [Abstract][Full Text] [Related]
10. [The inhibitory effect of high energy shock waves on bladder tumor cell line BIU-87 in vitro]. Guo YL Zhonghua Yi Xue Za Zhi; 1992 Sep; 72(9):522-4, 572. PubMed ID: 1338511 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of metastatic renal cell carcinomas expressing somatostatin receptors by a targeted cytotoxic analogue of somatostatin AN-238. Plonowski A; Schally AV; Nagy A; Kiaris H; Hebert F; Halmos G Cancer Res; 2000 Jun; 60(11):2996-3001. PubMed ID: 10850448 [TBL] [Abstract][Full Text] [Related]
12. Suppressive effect of high energy shock waves on tumor cells. Chen CL; Guo ZH; Zhao Y; Yan CY; Pu JX; Chen ZX; Zhang R Chin Med J (Engl); 1991 Jul; 104(7):548-51. PubMed ID: 1879217 [TBL] [Abstract][Full Text] [Related]
13. Treatment of human renal cell carcinoma with high-energy shock waves--a new in vivo/in vitro model. Roessler W; Rothgangel B; Hofstaedter F; Wieland WF Urol Int; 1995; 55(1):1-5. PubMed ID: 7571174 [TBL] [Abstract][Full Text] [Related]
14. Disturbance of cellular calcium homeostasis by in vitro application of shock waves. Suhr D; Brümmer F; Irmer U; Hülser DF Ultrasound Med Biol; 1996; 22(5):671-9. PubMed ID: 8865562 [TBL] [Abstract][Full Text] [Related]
15. Growth and major histocompatibility antigen expression regulation by IL-4, interferon-gamma (IFN-gamma) and tumour necrosis factor-alpha (TNF-alpha) on human renal cell carcinoma. Hillman GG; Puri RK; Kukuruga MA; Pontes JE; Haas GP Clin Exp Immunol; 1994 Jun; 96(3):476-83. PubMed ID: 8004818 [TBL] [Abstract][Full Text] [Related]
16. In vitro cytotoxic activity of lithotripter shock waves combined with adriamycin or with cisplatin on L1210 mouse leukemia cells. Wilmer A; Gambihler S; Delius M; Brendel W J Cancer Res Clin Oncol; 1989; 115(3):229-34. PubMed ID: 2753925 [TBL] [Abstract][Full Text] [Related]
17. The efficiency of urolithiasis treatment with extracorporeal lithotripsy in relation to the shock waves frequency. Azat Ch; Pacik D; Varga G; Hajny M Bratisl Lek Listy; 2010; 111(12):644-6. PubMed ID: 21384732 [TBL] [Abstract][Full Text] [Related]
18. Time- and concentration-dependent inhibition of the clonogenic growth of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced murine bladder tumor cell lines by cis-diamminedichloroplatinum(II). Niell HB; Wood CA; Mickey DD; Soloway MS Cancer Res; 1982 Mar; 42(3):807-11. PubMed ID: 7199379 [TBL] [Abstract][Full Text] [Related]
19. In vivo effect of high energy shock waves on growth and metastasis of the heterografted tumors of nude mice. Zhou L; Guo Y Chin Med J (Engl); 1996 Feb; 109(2):157-61. PubMed ID: 8758343 [TBL] [Abstract][Full Text] [Related]
20. Influence of high-energy shock waves and cisplatin on antitumor effect in murine bladder cancer. Lee KE; Smith P; Cockett AT Urology; 1990 Nov; 36(5):440-4. PubMed ID: 2238303 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]